About ZOLL Medical
ZOLL’s worldwide HQ is located in Chelmsford, Massachusetts, USA, with the UK office based in Runcorn, Cheshire. ZOLL Medical Corporation was founded in 1980. The company has more than 3,000 employees worldwide.
The founder, Paul M. Zoll, M.D., was the inventor of heart pacemaker technology in 1952. He was the first person to externally defibrillate the heart in 1956.
ZOLL Medical Corporation, an Asahi Kasei Group Company, develops and markets medical devices that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care.
The Asahi Kasei Group is a group of companies led by holding company Asahi Kasei Corp. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. With more than 30,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries.
ZOLL’s mission is to improve resuscitation outcomes by developing and marketing products that deliver:
- Superior clinical performance.
- Rapid therapy.
- Meaningful information.
- Higher user confidence.
- Economic value.
ZOLL will foster a company culture that expects a self-motivated, entrepreneurial spirit, and values each employee.
ZOLL will grow by remaining focused, building on their technology leadership, and providing unique high-quality products through worldwide distribution. These products help healthcare professionals, emergency responders, and lay rescuers save thousands of lives each year.